These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1568836)

  • 1. Antisense oligodeoxynucleotide: inhibitor of splicing of mRNA of human immunodeficiency virus.
    Daum T; Engels JW; Mag M; Muth J; Lücking S; Schröder HC; Matthes E; Müller WE
    Intervirology; 1992; 33(2):65-75. PubMed ID: 1568836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide-avidin conjugates.
    Boado RJ; Pardridge WM
    Bioconjug Chem; 1994; 5(5):406-10. PubMed ID: 7849069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
    Dinauer N; Lochmann D; Demirhan I; Bouazzaoui A; Zimmer A; Chandra A; Kreuter J; von Briesen H
    J Control Release; 2004 May; 96(3):497-507. PubMed ID: 15120905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus-1 proliferation by liposome-encapsulated sense DNA to the 5' tat splice acceptor site.
    Sullivan SM; Gieseler RK; Lenzner S; Ruppert J; Gabrysiak TG; Peters JH; Cox G; Richer L; Martin WJ; Scolaro MJ
    Antisense Res Dev; 1992; 2(3):187-97. PubMed ID: 1490070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologically active oligodeoxyribonucleotides--I: Syntheses and anti-HIV-1 activities of 5'-modified pentadecadeoxyribonucleotides.
    Hotoda H; Momota K; Furukawa H; Nakamura T; Kaneko M; Kimura S; Shimada K
    Nucleic Acids Symp Ser; 1993; (29):59-61. PubMed ID: 8247795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene.
    Schröder HC; Ugarkovic D; Merz H; Kuchino Y; Okamoto T; Müller WE
    FASEB J; 1990 Oct; 4(13):3124-30. PubMed ID: 1698680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
    Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
    Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
    Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients.
    Geissler RG; Muth J; Maurer A; Mentzel U; Mag M; Engels JW; Hoelzer D; Ganser A
    Ann Hematol; 1995 Aug; 71(2):89-95. PubMed ID: 7544629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
    Matsukura M; Zon G; Shinozuka K; Robert-Guroff M; Shimada T; Stein CA; Mitsuya H; Wong-Staal F; Cohen JS; Broder S
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4244-8. PubMed ID: 2471199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short partially double-stranded oligodeoxynucleotide induces reverse transcriptase/RNase H-mediated cleavage of HIV RNA and contributes to abrogation of infectivity of virions.
    Matskevich AA; Ziogas A; Heinrich J; Quast SA; Moelling K
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1220-30. PubMed ID: 17209763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides.
    Demirhan I; Hasselmayer O; Hofmann D; Chandra A; Svinarchuk FP; Vlassov VV; Engels J; Chandra P
    Virus Genes; 1995 Jan; 9(2):113-9. PubMed ID: 7732657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
    Lund OS; Nielsen JO; Hansen JE
    Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.
    Chang HK; Gendelman R; Lisziewicz J; Gallo RC; Ensoli B
    Gene Ther; 1994 May; 1(3):208-16. PubMed ID: 7584083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
    Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
    FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
    Anazodo MI; Wainberg MA; Friesen AD; Wright JA
    J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
    Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
    Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.
    Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.